InVivo Therapeutics Holdings Corp. (NVIV) announced today that
InVivo’s Director of Research Richard Layer, Ph.D., has been invited to
speak at the Joint Symposium of the 4th International Neural
Regeneration Symposium (INRS2014), 9th Asia Pacific Symposium on Neural
Regeneration (APSNR2014), and 6th International Spinal Cord Injury
Treatment and Trials Symposium (ISCITT2014), to be held September 6-8,
2014 in Nanjing, China (website: http://www.inrs-nrr.org/CN/model/index_en.shtml).
“It is a great honor to be invited to speak at this international
symposium,” Dr. Layer said. “InVivo is a leader in the field, and I look
forward to presenting the company’s approach to development and
translation of new treatments for spinal cord injury to my international
colleagues.” The goal of the Joint Symposium is to provide an
international platform for presenting new discoveries, to exchange new
ideas, to stimulate new collaborations, to promote translation from
basic science to the clinic, and to educate professionals in the field
of neural regeneration.
Dr. Layer will present an overview of the company’s biomaterials
technology platform, including its degradable polymer Neuro-Spinal
Scaffold. Recently, following approval from the U.S. Food and Drug
Administration (FDA), InVivo Therapeutics initiated a clinical study of
its Neuro-Spinal Scaffold. This study is intended to capture preliminary
safety and effectiveness data of the Neuro-Spinal Scaffold in up to five
human subjects with acute thoracic spinal cord injury.
About InVivo Therapeutics
InVivo Therapeutics Holdings Corp. is a pioneering biomaterials and
biotechnology company with a focus on treatment of spinal cord injuries.
The company was founded in 2005 with proprietary technology co-invented
by Robert Langer, ScD., Professor at Massachusetts Institute of
Technology, and Joseph P. Vacanti, M.D., who is affiliated with
Massachusetts General Hospital. In 2011 the Company earned the David S.
Apple Award from the American Spinal Injury Association for its
outstanding contribution to spinal cord injury medicine. The publicly
traded company is headquartered in Cambridge, MA. For more details,
visit, www.invivotherapeutics.com.
Copyright Business Wire 2014